IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 13 9:20 PM | Monia Brett P | Proposed Sale | 100,000 | $78.01 | $7.8M | — | View → |
| May 4, 2026 | May 6 9:27 PM | Joseph LoscalzoDirector | Sale | 77,289 | $75.06 | $5.8M | 36,330(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Joseph Klein IIIDirector | Sale | 10,111 | $73.51 | $743.2K | 11,014(D) | View → |
| May 4, 2026 | May 4 10:05 PM | LOSCALZO JOSEPH | Proposed Sale | 54,321 | $80.00 | $4.3M | — | View → |
| Apr 28, 2026 | Apr 30 8:21 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 1,626 | $71.79 | $116.7K | 44,909(D) | View → |
| Apr 28, 2026 | Apr 28 8:12 PM | Baroldi Joseph | Proposed Sale | 1,626 | $71.79 | $116.7K | — | View → |
| Apr 15, 2026 | Apr 17 11:19 PM | Lynne B ParshallDirector | Sale | 5,000 | $76.27 | $381.4K | 51,344(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Sale | 4,902 | $75.17 | $368.5K | 23,713(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Brian BirchlerEVP, Corp and Development Ops | Sale | 973 | $75.04 | $73.0K | 67,500(D) | View → |
| Apr 16, 2026 | Apr 17 11:19 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 5,619 | $74.56 | $419.0K | 46,535(D) | View → |
| Apr 16, 2026 | Apr 16 10:49 PM | Jenne Kyle | Proposed Sale | 4,902 | $75.40 | $369.6K | — | View → |
| Apr 16, 2026 | Apr 16 10:47 PM | Birchler Brian | Proposed Sale | 973 | $75.40 | $73.4K | — | View → |
| Apr 16, 2026 | Apr 16 10:45 PM | Baroldi Joseph | Proposed Sale | 5,619 | $75.40 | $423.7K | — | View → |
| Apr 1, 2026 | Apr 2 11:43 PM | Joseph Klein IIIDirector | Sale | 22,321 | $75.55 | $1.7M | 11,014(D) | View → |
| Apr 2, 2026 | Apr 2 11:43 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Sale | 6,193 | $74.05 | $458.6K | 16,348(D) | View → |
| Mar 3, 2026 | Mar 31 9:28 PM | Diaz Allene M. | Proposed Sale | 68,800 | $79.50 | $5.5M | — | View → |
| Mar 19, 2026 | Mar 24 8:43 PM | Schneider Eugene | Proposed Sale | 5,812 | $70.97 | $412.5K | — | View → |
| Mar 19, 2026 | Mar 23 11:36 PM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 5,812 | $70.97 | $412.5K | 63,890(D) | View → |
| Mar 19, 2026 | Mar 19 8:01 PM | Schneider Eugene | Proposed Sale | 5,812 | $70.97 | $412.5K | — | View → |
| Mar 17, 2026 | Mar 18 9:19 PM | HOUGEN ELIZABETH LEVP, Finance & CFO | Sale | 10,172 | $73.21 | $744.7K | 82,660(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Jan 21 1:20 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Grant/Award | 7,500 | $79.67 | 16,600(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Option Exercise | 11,119 | — | 20,830(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Holly B. KordasiewiczEVP, Chief Development Officer | Grant/Award | 24,900 | — | 45,730(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 7,013 | — | 29,664(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Grant/Award | 35,475 | $0.00 | 37,725(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | HOUGEN ELIZABETH LEVP, Finance & CFO | Option Exercise | 28,729 | — | 55,940(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | HOUGEN ELIZABETH LEVP, Finance & CFO | Grant/Award | 47,245 | $0.00 | 68,825(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 17,377 | — | 43,029(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Shannon L. DeversEVP, Chief Human Resources Ofc | Grant/Award | 35,475 | $0.00 | 52,704(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Brian BirchlerEVP, Corp and Development Ops | Option Exercise | 20,089 | — | 41,126(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Brian BirchlerEVP, Corp and Development Ops | Grant/Award | 35,475 | $0.00 | 50,801(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 21,055 | — | 17,434(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | BENNETT C FRANKEVP, Chief Scientific Officer | Grant/Award | 35,475 | $0.00 | 27,109(D) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 19,887 | — | 5,474(I) | View → |
| Jan 15, 2026 | Jan 21 1:18 AM | Joseph BaroldiEVP, Chief Business Officer | Grant/Award | 39,375 | $0.00 | 9,374(I) | View → |
← Previous
Page 3 of 3